EcoDrugPlus

Solute Carrier Family 6 Member 1b

Ensembl ID : ENSIPUG00000011974
Gene Symbol: SLC6A1B
3 Cross references
209 Possible Orthologues:

Solute Carrier Family 6 Member 2

Ensembl ID : ENSIPUG00000017028
Gene Symbol: SLC6A2
3 Cross references
203 Possible Orthologues:

Solute Carrier Family 6 Member 3

Ensembl ID : ENSIPUG00000000089
Gene Symbol: SLC6A3
4 Cross references
166 Possible Orthologues:

Solute Carrier Family 6 Member 4a

Ensembl ID : ENSIPUG00000019593
Gene Symbol: SLC6A4A
3 Cross references
201 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSIPUG00000002198
Gene Symbol: SLC6A9
3 Cross references
208 Possible Orthologues:

Solute Carrier Family 9 Member A3, Tandem Duplicate 1

Ensembl ID : ENSIPUG00000008503
Gene Symbol: SLC9A3.1
4 Cross references
234 Possible Orthologues:

Somatostatin Receptor 1a

Ensembl ID : ENSIPUG00000001536
Gene Symbol: SSTR1A
3 Cross references
158 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSIPUG00000011452
Gene Symbol: SSTR2
4 Cross references
192 Possible Orthologues:

Somatostatin Receptor 2a

Ensembl ID : ENSIPUG00000011773
Gene Symbol: SSTR2A
3 Cross references
192 Possible Orthologues:

Somatostatin Receptor 3

Ensembl ID : ENSIPUG00000013350
Gene Symbol: SSTR3
3 Cross references
188 Possible Orthologues:

Sphingosine Kinase 2

Ensembl ID : ENSIPUG00000000163
Gene Symbol: SPHK2
3 Cross references
202 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSIPUG00000024823
Gene Symbol: S1PR1
3 Cross references
200 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).